Cargando…

Clinical outcomes and visual prognostic factors in congenital aniridia

BACKGROUND: Evaluate outcomes and identify prognostic factors in congenital aniridia. METHODS: Retrospective interventional case series of patients with congenital aniridia treated between 2012–2020. Ocular examination and surgical details were collected. Surgical failure was defined as disease prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobson, Adam, Mian, Shahzad I., Bohnsack, Brenda L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131660/
https://www.ncbi.nlm.nih.gov/pubmed/35614435
http://dx.doi.org/10.1186/s12886-022-02460-5
_version_ 1784713219976200192
author Jacobson, Adam
Mian, Shahzad I.
Bohnsack, Brenda L.
author_facet Jacobson, Adam
Mian, Shahzad I.
Bohnsack, Brenda L.
author_sort Jacobson, Adam
collection PubMed
description BACKGROUND: Evaluate outcomes and identify prognostic factors in congenital aniridia. METHODS: Retrospective interventional case series of patients with congenital aniridia treated between 2012–2020. Ocular examination and surgical details were collected. Surgical failure was defined as disease progression or need for additional surgery for same/related indication. Kaplan–Meier survival curves, Wilcoxon test, and univariate and multivariate linear regression analyses were performed. RESULTS: Ninety-four patients with congenital aniridia presented at median 19.0 years. Two-thirds of patients underwent ≥ 1intraocular surgery, with average of 1.7 ± 2.3 surgeries/eye. At final follow-up (median 4.0 years), 45% of eyes had undergone lensectomy. Aphakic eyes showed worse visual acuity (VA) than phakic or pseudophakic eyes. Glaucoma affected 52% of eyes, of which half required IOP-lowering surgery. Glaucoma drainage devices showed the highest success rate (71%) at 14.2 ± 15.4 years of follow-up. Keratopathy affected 65% of eyes and one-third underwent corneal surgery. Keratoprosthesis had the longest survival rates at 10-years (64% with 95% CI [32,84]). LogMAR VA at presentation and final follow-up were not statistically different. Half of patients were legally blind at final follow-up. Final VA was associated with presenting VA, glaucoma diagnosis, and cataract or keratopathy at presentation. Penetrating keratoplasty and keratoprosthesis implantation correlated with worse BCVA. CONCLUSIONS: Most aniridic patients in this large US-based cohort underwent at least 1 intraocular surgery. Cataract, glaucoma, and keratopathy were associated with worse VA and are important prognostic factors to consider when managing congenital aniridia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12886-022-02460-5.
format Online
Article
Text
id pubmed-9131660
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91316602022-05-26 Clinical outcomes and visual prognostic factors in congenital aniridia Jacobson, Adam Mian, Shahzad I. Bohnsack, Brenda L. BMC Ophthalmol Research BACKGROUND: Evaluate outcomes and identify prognostic factors in congenital aniridia. METHODS: Retrospective interventional case series of patients with congenital aniridia treated between 2012–2020. Ocular examination and surgical details were collected. Surgical failure was defined as disease progression or need for additional surgery for same/related indication. Kaplan–Meier survival curves, Wilcoxon test, and univariate and multivariate linear regression analyses were performed. RESULTS: Ninety-four patients with congenital aniridia presented at median 19.0 years. Two-thirds of patients underwent ≥ 1intraocular surgery, with average of 1.7 ± 2.3 surgeries/eye. At final follow-up (median 4.0 years), 45% of eyes had undergone lensectomy. Aphakic eyes showed worse visual acuity (VA) than phakic or pseudophakic eyes. Glaucoma affected 52% of eyes, of which half required IOP-lowering surgery. Glaucoma drainage devices showed the highest success rate (71%) at 14.2 ± 15.4 years of follow-up. Keratopathy affected 65% of eyes and one-third underwent corneal surgery. Keratoprosthesis had the longest survival rates at 10-years (64% with 95% CI [32,84]). LogMAR VA at presentation and final follow-up were not statistically different. Half of patients were legally blind at final follow-up. Final VA was associated with presenting VA, glaucoma diagnosis, and cataract or keratopathy at presentation. Penetrating keratoplasty and keratoprosthesis implantation correlated with worse BCVA. CONCLUSIONS: Most aniridic patients in this large US-based cohort underwent at least 1 intraocular surgery. Cataract, glaucoma, and keratopathy were associated with worse VA and are important prognostic factors to consider when managing congenital aniridia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12886-022-02460-5. BioMed Central 2022-05-25 /pmc/articles/PMC9131660/ /pubmed/35614435 http://dx.doi.org/10.1186/s12886-022-02460-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jacobson, Adam
Mian, Shahzad I.
Bohnsack, Brenda L.
Clinical outcomes and visual prognostic factors in congenital aniridia
title Clinical outcomes and visual prognostic factors in congenital aniridia
title_full Clinical outcomes and visual prognostic factors in congenital aniridia
title_fullStr Clinical outcomes and visual prognostic factors in congenital aniridia
title_full_unstemmed Clinical outcomes and visual prognostic factors in congenital aniridia
title_short Clinical outcomes and visual prognostic factors in congenital aniridia
title_sort clinical outcomes and visual prognostic factors in congenital aniridia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131660/
https://www.ncbi.nlm.nih.gov/pubmed/35614435
http://dx.doi.org/10.1186/s12886-022-02460-5
work_keys_str_mv AT jacobsonadam clinicaloutcomesandvisualprognosticfactorsincongenitalaniridia
AT mianshahzadi clinicaloutcomesandvisualprognosticfactorsincongenitalaniridia
AT bohnsackbrendal clinicaloutcomesandvisualprognosticfactorsincongenitalaniridia